Dr. Oz, the head of CMS, is now calling the plans "CHOICE Arrangements" and asking states to do more to support them.

In other words, the entry of biosimilars into a reference product's market does not guarantee patient savings. Benefit design ...

"Understanding the financial challenges LGBTQ+ adults face when accessing health care can help identify persistent gaps in ...

A Milwaukee hospital alleges CVS used its control of a PBM, specialty pharmacy and third-party administrator to reduce ...

Nearly 70% of the estimate rests on payments above an insurer-calculated benchmark that a federal appeals court recently ...

This not only would be the fifth-consecutive year of elevated cost growth but also would be the largest annual increase since ...

Healthier employers are moving away from the community-rated market, and that's a problem for the community-rated market, according to a new Congressional Budget Office report.

Employers will need to take stock of any changed reporting obligations and assess whether they are going to continue collecting employee demographic information in light of the changes.

Regulators in are warning would-be insurance producers against trusting recruiters who seem a little too helpful.

However, nearly two-thirds (65.5%) of employers cite employee education as the most common HSA concern while just half ...

UnitedHealth Group's UnitedHealthcare unit has posted a list of procedure codes for about 1,700 procedures that will no ...

These agreements bring the total number of pharmaceutical manufacturers with MFN deals to 26, covering nearly 90% of the ...